Taken together, these findings highlight the utility of molecular network analyses for identifying priority nodes in complex biological systems and suggest that genes such as OPRM1, GSK3B, and EGFR may represent strategic targets for more effective and personalized pharmacological treatments in MDD. This evidence concerns the gene OPRM1 and major depressive disorder.